ANTIEPILEPTICS Flashcards

1
Q

Seizures

A

TRANSIENT alteration of behavior due to disordered, synchronous and rhythmic firing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Epilepsy

A

Sudden recurrent attacks of motor, sensory, autonomic, psychic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Motor component is the

A

Seizure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Epilepsy classification

A

Partial (focal) : begin one hemisphere of the brain

Generalized seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Simple partial

A

no LOC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Complex partial seizures

A

Loss of concsciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Partial with secondary generalized seizures

A

evolves to both sides of the brain, convulsive seizure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Generalized seizures begin where?

A

both hemispheres of the brain and usually result in LOC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Absence seizures also known as

A

petit mal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of generalized

A
absence
myoclonic
tonic-clonic
tonic
clonic
atonic  (akinetic) 
Status epilepticus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Status Epilepticus

A

any seizure that last more than 20 minutes OR

seizures of sufficient frequency that the patient does not regain consciousness between episodes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Status Epilepticus

A

more than 30-60 minutes –> CNS damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give first in SE

A

fast acting medications f/B

Longer acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neuromuscular blocking drugs are

A

CONTRAINDICATED or not the first drug of choice for SE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DO not stop seizure

A

NMB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug of choice for Absence seizure

A

Ethosuximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Stratus Epilepticus first line for treatment

A

LORAZEPAM - CHOICE drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Anti-epileptic and drug interactions

no effect on these meds.

A

Chronic anticonvulsant therapy are resistant Nondepolarzing NMJ such as ROCURONIUM (INCREASE rate)
No effect on ATRACURIUM, MIVACURIUM, CISATRACURIUM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Patients being treated with AEDs have increased dose requirement

A

THIOPENtAL
PROPOFOL
MIDAZOLAM
OPIODS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

AED numbers interaction gbecause

A

Highly metabolized in the liver

They are inducers/ inhibitors or both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Highly protein bound to this protein

A

ALBUMIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

For those AED agents that are highly protein bound,

A

displacement from binding site by other highly poroten bound drugs can occur and lead to increase plasma concentration of the AED medications
HYPOALBUMINIA can results in INCREASE PLASMA CONCENTRATION of unbound AED, resulting in toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Acute administration of phenytoin

A

Prolong Non-Depolarizing neuromuscular blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Decrease glutamate (excitatory neurotransmitter) synaptic activity

A

NMDA (N-methyl-D-aspartate) receptor antagonists
• AMPA/kainate receptor antagonist
4. Inhibition of brain carbonic anhydrase enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Enhance GABA-mediated neuronal inhibition synaptic activity

A
  • GABA (γ-aminobutyric acid) modulators/enhancers
  • GABA (γ-aminobutyric acid) re-uptake inhibitors
  • GABA (γ-aminobutyric acid) transaminase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

• Antiepileptic drugs (AEDs) exert their anticonvulsant activity by
the following proposed general mechanisms:
.

A
  1. Inactivate either voltage-gated Na+ or voltage-gated Ca++ currents
    via blockade. Some AEDs can inactive both currents
    2.Enhance GABA-mediated neuronal inhibition synaptic activity
  2. Decrease glutamate (excitatory neurotransmitter) synaptic activity
  3. Inhibition of brain carbonic anhydrase enzyme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

AEDs and Pregnancy

A
  • AEDs can cause teratogenic effects
  • NEURAL TUBE defects such as spina bifida can occur, cleft lip & palate
  • Phenobarbital, phenytoin, carbamazepine, valproic acid increase the incidence of congenital malformations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

AVOIDED AT ALL COST in pregnancy

A

Phenobarbital, phenytoin, carbamazepine, valproic acid increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

the highest incidence of teratogenic malformations of all AEDs.

A

VALPROIC ACID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

AED

A
First generation (Traditional, old) 
Second generation (newer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Second generation AED

A
Pregabalin
Lacosamide
Rufinamide
Vigabatrin,
EGOzabine
perampanel 
eslicarbazepine,	and	brivaracetam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Benzo

A

display anxiolytic, sedative, muscle relents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Benzo MOA

A

Potentiate GABA-mediated neuronal inhibition by binding to the benzodiazepine receptor site on GABAA receptors, which increases
the frequency of GABA-mediated ion channel opening and increases chloride permeability and thereby leads to cellular hyperpolarization and inhibition of neuronal firing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

• Diazepam

A

Useful for treatment of status epilepticus

• Has a rapid onset and short duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Diazepam VS LORAZEPAM

A

• Has a faster onset but has a shorter duration of action than
lorazepam since diazepam is more lipophilic (gets in and out of the
CNS faster than lorazepam)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Diazepam important

A

SEVERAL ACTIVE METABOLITES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

First benzo for SE

A

LORAZEPAM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Lorazepam

A

onset, not as fast as diazepam still fast

Less liphophillic than diazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

pHenytoin class________ class anti-epileptic agent
• Available in both

A

Hydantoin ;ORAL and IV formulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Phenytoin MOA

A

Fast Na+ Channel Blocker
• Regulates neuronal excitability and prevents the spread of seizure
activity from a seizure focus by regulating Na+ across neuronal
membranes. The effect is mediated by a slowing of the rate of
recovery of the Na+ channel
• Associated with use-dependent blockade of Na+ channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Pharmacological effects of Phenytoin

A
Exerts	anti-seizure	activity	without	causing	general	depression	of	
the	CNS	(usually	not	associated	with	excessive	sedation)	
• In	toxic	cases,	it	may	produce	excitatory	CNS	signs	&	symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Phenytoin is a (acid/base)

A

WEAK ACID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Phenytoin pharmacokinetics
Protein binding ____________
Half life
Half life increases if concentration is

A

Protein Binding: >90% protein bound
• Primarily bound to albumin
• Plasma t 1/2: 6-24 hours but the t1/2 increases when phenytoin’s
plasma concentration becomes > 10 mcg/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

• Metabolism of Phenytoin

A

Liver via several CYP 450 enzyme systems
• Exhibits saturable metabolism OR Michaelis-Menten pharmacokinetics (a type of non-linear pharmacokinetics)
• Metabolized to inactive metabolites
• Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

with plasma concentrations < 10 mcg/mL, phenytoin follows

A

linear

pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

with plasma concentrations > 10 mcg/mL, the enzymes necessary for metabolism of phenytoin
pharmacokinetics (zero-order kinetics).

A

become saturated and the half-life

becomes dose-dependent and elimination follows non-linear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Target total concentration

A

10-20 mcg/ml (1-2mcg/ml)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

CLASSIC ENZYME INDUCER

A

PHENYTOINC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

METABOLIZED BY

A

multiple CYP 450 Enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Phenytoin highly protein bound to

A

Albumin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Since phenytoin is metabolized by CYP 450 enzymes, administering phenytoin with CYP 50 inducers or inhibitors will alter phenytoin’s plasma

A

CYP 450 inducers will decrease phenytoin’s plasma concentrations
• CYP 450 inhibitors will increase phenytoin’s plasma concentrations
Administering other drugs that are bound to albumin will increase phenytoin’s free, unbound concentration and potentially increase the risk of toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

IM never an option for

A

Phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

• IV infusion rate should NEVER exceed________

why?

A

exceed 50 mg/min
The propylene glycol diluent in the phenytoin injection dosage formulation is a known cardiac depressant and can cause severe hypotension, bradycardia and other cardiac arrhythmias if infused too fast!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

IV infusion PHENYTOIN not to infused fast because of the

A

Diluent that’s in there

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Watch drug-drug compatibility interaction so precipitation does not occur
• AVOID ______
• Phenytoin precipitates in solutions with ph of

A

dextrose solutions

pH < 7.8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

CYP 450 inducers will (increase/decrease)

A

decrease phenytoin’s plasma concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

• CYP 450 inhibitors will (Increase/decrease)

A

increase phenytoin’s plasma concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Non dose related phenytoin

A
Steven johnson Syndrome
FETAL abnormalities (Fetal Hydantoin syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Fosphenytoin

A

prodrug of phenytoin
water soluble
INJECTABLE Only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Fosphenytoin routes

A

IV or IM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Once converted fosphenytoin is

A

highly protein bound

effect comes from phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Metabolism of phenytoin

A

by PHOSPHOTASE ENZYMES in the liver and RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

No drugs are known to

A

interferer with the metabolic conversion of fosphenytoin to phenytoin

64
Q

Fosphenytoin compatible with either _____or _____

A

NS or D5W

65
Q

Do not need IV filter for

A

Fosphenytoin

66
Q

Fosphenytoin allow the administration of IV form

A

Faster

67
Q

Loading dose of fosphenytoin

A

15-20 PE/Kg for SE

PE is PHENYTOIN Equivalents

68
Q

Fosphenytoin and phenytoin is not a

A

1:1

69
Q

Because of the risk of hypotension, administer fosphenytoin no faster than _______

A

150mg PE/min (3x as fast)

70
Q

Carbamazepine (TegretoL)

A

TCA chemically

Oral agent

71
Q

Tegretol vs phenytoin: 2 differences

A

1.Produces therapeutic responses in manic depressive patients
2 Has an anti-diuretic effect that is sometimes associated with increase concentration of ADH in the plasma

72
Q

Mechanism of action tegretol

A

Fast Na+ channel blocker

THERE IS AN active metabolite

73
Q

One of the Clinical uses of Tegretol for NON-SEIZURE

A

TRIGEMINAL NEURALGIA

74
Q

Tegretol has a unique metabolic pathway

A

AUTO-INDUCER (induces its own metabolism)

75
Q

Tegretol is metabolized by the liver to

A

an active metabolite, which is then burster metabolized into inactive metabolites & Excreted via urine

76
Q

Tegretol requires

A

Adequate renal and liver function

77
Q

Tegretol and CYP 450

A

Is a strong enzyme inducer of CYP450 and NON CYP 450 liver enzymes

78
Q

Adverse effects of Tegretol

A

CAN CAUSE SIADH (water retention and hyponatremia)

79
Q

Nondepolarizing NMB such as Vecu and rocuronium

A

May have resistance occur in patients CHRONICALLY receiving anticonvulsant agents such as tegretol or phenytoin
IF TEGRETOL is being used pre-operatively, patient will be resistant and is a KNOWN-GUARANTEED INTERACTION (standard dose of vec or ROC won’t work)

80
Q

Will a standard dose of Nondepoleraizing NMB have safe effect of chronically treated patient

A

no

81
Q

Phenobarbital is a

A

long acting barbiturates, oral

82
Q

Phenobarbital MOA

A

binds to GABAa receptores via the barbiturate binding site and increases GABA mediated chloride influx.
Prolongs the opening of the chloride channels, which increases chloride influx , which intern increases membrane polarization (causes HYPERPOLARIZATION)

83
Q

Phenobarbital has ______metabolites

A

NO ACTIVE METABOLITES

84
Q

Phenobarbital half life is _______and about

A

80-100 hours

85
Q

Phenobarbital metabolism

Interact with what system

A

CYP 450 Enzyme inducer and UGT enzymes system

86
Q

Most common side effect of PHENOBARBital

A

Sedation, Sedation

87
Q

What is primidone

A

Oral only anti-epileptic, prodrugs

2 active metabolites (phenobarbital and PEMA)

88
Q

ETHOSUXIMIDE (succinimide)

A

oral only
100% bioavaillabitliy
0% protein binding
NO drugs to drug interaction

89
Q

Ethosuximide type (maintenance)

A

T type Ca2+ channel blocker reduces the flow of Ca2+ through that fast channel.

90
Q

Only clinical use of Ethosuximide

A

ABSENT SEIZURE

91
Q

Valproic acid is

A

non-selective anti-seizure medication

CAN BE USED FOR MAJORITY OF SEIZURE BECAUSE MULTIPLE MECHANISM OF ACTION

92
Q

Valproic acid MOA (4)

A
  • fast Na+ Channel blocker
  • T type Ca2+ blocker
  • increases GABA production by stimulating GABA synthesis
  • inhibiting GABA metabolism
93
Q

Non seizure indication for valproic acid

A

Headache prevention

94
Q

GI irritant drugs

A

Valproic acid , GI, GI

95
Q

Valproic acid metabolism

A

Extensive metabolism in the liver,
NON dependent on CYP 450
Dependent on UGT enzymes
Has active metabolites.

96
Q

What bad about valproic acid

A
  • Lots of side effects

- drug to drug interactions

97
Q

Valproic acid given with Phenytoin and diazepam

A

can displace and increase the free plasma concentration of those medication (phenytoin and diazepam)

98
Q

Valproic acid and CYP 450

A

Strong enzyme inhibitor of CYP 450 and UGT enzymes

99
Q

Valproic acid is an another drug that display

A

NON LINEAR PHARMACOKINETICS

100
Q

This drug displays NON-LINEAR PHARMACOKINETICS

A

Valproic acid

101
Q

Trileptal (oxcarbazepine)

A

prodrugs (not related to carbamezipine)

CONVERT TO ACTIVE METABOLITES that carries out reaction (10-monohydroxy metabolite)

102
Q

Trileptal (oxcarbazepine) metabolism

ALWAYS eliminated

A
UGT enzymes (no auto induction) 
Phase II Glucuronide CONJUGATION and renal elimination
103
Q

Trileptal (oxcarbazepine) metabolism

A

Fast Na+ Channel blocker

104
Q

Trileptal (oxcarbazepine) both an enzyme

A

strong enzyme inducer/ inhibitor dependent on the pathway.

105
Q

Trileptal can also causes

A

SIADH

106
Q

Lamotrigine (Lamictal)

A

Broader spectrum of seizures

107
Q

Exact mechanism of action of lamictal is

A

unknown

but decrease excitatory amino acids (glutamate and aspartate)

108
Q

Protein binding of lamictal

half life is

A

55%

25 hours

109
Q

Drug- Drug interaction : lamictal

A
  • Not an inhibitor or inducer of CYP450

- Valproic acid decrease lamotrigine metabolism and increases its serum concentration and half life.

110
Q

Hallmark of Lamictal

2 rashes and _____related

A

RASH (dose related) is the most serious potential adverse effect
2Stevens-Johnson Syndrome
Toxic Epidermal necrolysis (TEN)

111
Q

Levetiracetam is a

A

Pure S-isomer ( not racemic)

FATAL and life threatening by which levetiracetam

112
Q

Precise of MOA keppra

A

suggested binds to synaptic vesicle glycoprotein SV2A in the brain and alter its function and this may mediate the anticonvulsant activity

113
Q

Absorption of Keppra is

A

100%

114
Q

CLINICAL USES of Keppra

A

PREVENTION In surgical patients of seizure in some NEURO patients

115
Q

Pharmacokinetics of Keepra (good drug because)

Excretion via ___________exclusive?

A

low protein bound
Not extensively metabolized.
ISSUE: EXCLUSIVE EXCRETION via kidneys

116
Q

Brivaracetam (briviact)

A

expensive
Partial onset seizures in patients
SCHEDULED V meds (abuse potential)

117
Q

Brivaracetma is same as keppra pharmacokinetics

A

100% oral bioavailability

Half life is 9 hours

118
Q

Brivaracetam Metabolized through the

A

CYP450 Pathway

119
Q

GABAPENTIN is a

A

Related to the neurotransmitter GABA but DOES NOT modify GABAa or GABAb ligand binding.

120
Q

GABAPENTIN both a

A

Analgesic and antiepileptic drug

121
Q

**MOA of GABAPENTIN

A

Bind to alpha 2 delta subunit of voltage dependent Ca2+ Channels, and inactivates them.

122
Q

GABAPENTIN protein binding

A

low

NOT CYP450 dependent

123
Q

Do not abruptly discontinue those 2 medications

A

GABAPENTIN, or lyrica

May have withdrawal syndrome

124
Q

2 Clinical uses of gabapentin

A

POST HERPETIC NEURALGIA

Diabetic neuropathy

125
Q

Pregabalin (LYRICA) is a derivative of

A

GABA and Chemically similar to gabapentin
Does NOT DIRECTLY BIND TO GABAa, GABAb,
DOES NOT AUGMENT Gabaa responses or have effects on GABA uptake or degradation

126
Q

Lyrica

A

Schedules V
analgesic and antiepileptic effect
Same MOA as gabapentin (voltage gated Ca2+)

127
Q

Low protein bound lyricA?

A

yes

128
Q

CLINICAL use of lyrica

A

nerve pain syndrome

pain syndrome

129
Q

ANESTHESIA IMPLICATIONS of GABAPENTIN
Decrease 3 things
when given ?
Side effects ; 3 possible

A
  • Decrease opioid requirements/ consumption post op
  • Decrease early post op pain
  • Decrease post of N/V

Given typically 2 hours prior to surgey
can increase risk of dizziness, sedation, and confusion post op
Exact mechanism is known for the above effects.

130
Q
Topiramate:
Route
Potentiates what?
Enhances ? 
NO effects on \_\_\_\_\_\_
A

oral only
Fast voltage gated Na channel blocker
Enhances post synaptic GABAa, receptor currents.
low protein bound
Potentiates?
No effects on concentration of other medications

131
Q

Decrease serum concentration of topiramate

A

phenytoin
Carbamezipine
Valproic acid

132
Q

Most common adverse effects TOPAMAX

A

PSYCHOMOTOR SLOWRING
Difficulty with memory.
HYPERCHLOREMIC METABOLIC ACIDOSIS

133
Q

Zonisamide

A

Sulfa derivative

134
Q

Zonisamide metabolism ***

Half life is

A

• Extensively binds to erythrocytes, resulting in an eight-fold higher concentration in red blood cells (RBC) than in plasma
Plasma t1/2 = ~63 hours

135
Q

Seizure meDICATION HALF LIFE ______

A

long

136
Q

PHENYTOINC , CARBAMEZAPINE < PHENOBARBITLA

A

Are all enzyme inducers

137
Q

LACOSAMIDE (VIMPAT)

A

Extremely expensive

Selectivlty enhances slow inactivation of voltage gated Na+ channels

138
Q

Lacosamide Metabolism

A

metabolized CYP 450 enzymes

139
Q

Lacosamide can cause

A

Can cause HB
dose dependent
Afib or aflutter

140
Q

Rufinamide

A

Triazole derivative

Modulation of the activity of Na channel

141
Q

CLINICAL USE of RUFINAMIDE (hard to treat)

A

Lennox-GASTAUT SYNDROME

142
Q

Adverse effects of RUFINAMIDE on conduction

A

SHORT QT syndrome

143
Q

VIGABATRIN is a

A

Irreversible inhibitor of GABA-T the enzyme responsible for the metabolism of the inhibitory neurotransmitter GABA

144
Q

Vigabatrin side effects (3)

A

PERMANANT BLINDNESS
Peripheral neuropathy
Birth defects

145
Q

Ezogabine (POTIGA)

A

Potassium channel opener enhance transmembrane potassium current mediated by the KCNQ family of ion channels

146
Q

Pharmacokinetics of EZOGABINE
Metabolized by
Active metabolites?
effect on conduction?

A

several nonCYP
Has active meablites
PROLONG QT INTERVAL

147
Q

PERAMPANEL (FYCOMPA)

A

First and only AMPA Glutamate Receptor antagonist

148
Q

First and only AMPA Glutamate Receptor antagonist

A

Perampanel (Fycompa)

149
Q

Non-competitive at receptor site_____

A

stay longer

150
Q

Eslicarbazepine acetate : Protein binding is _____and excreted via _______

A

has a low protein binding

Via renal excretion

151
Q

Felbamate: when use

A

SEVERE TROUBLE, LAST effort medicaiton

152
Q

**Felbamate SERIOUS ADVERSE EFFECTS (2)

A
  • Aplastic anemia

- HEPATOTOXICITY

153
Q

Additional, only approved for partial seizures

A

PERAMPANEL

154
Q

Phenytoin Dose

A

16-20mg/Kg of TBW

155
Q

Fosphenytoin loading dose

A

15-20mg PE/kg for status epilepticus